Insulet (MEX:PODD) Other Net Income (Loss) : MXN-0 Mil (TTM As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Insulet Other Net Income (Loss)?

Insulet's Other Net Income (Loss) for the three months ended in Dec. 2024 was MXN0 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Dec. 2024 was MXN-0 Mil.

Insulet's quarterly Other Net Income (Loss) increased from Jun. 2024 (MXN-0 Mil) to Sep. 2024 (MXN0 Mil) but then stayed the same from Sep. 2024 (MXN0 Mil) to Dec. 2024 (MXN0 Mil).

Insulet's annual Other Net Income (Loss) declined from Dec. 2022 (MXN0 Mil) to Dec. 2023 (MXN-0 Mil) but then increased from Dec. 2023 (MXN-0 Mil) to Dec. 2024 (MXN0 Mil).

Insulet Other Net Income (Loss) Historical Data

The historical data trend for Insulet's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Insulet Other Net Income (Loss) Chart

Insulet Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Net Income (Loss)

Get a 7-Day Free Trial

Insulet Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Other Net Income (Loss)	Get a 7-Day Free Trial															-	-	-	-	-

Insulet Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN-0 Mil.

Insulet Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of Insulet's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Insulet Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Insulet Corp (MEX:PODD) » Definitions » Other Net Income (Loss)

Comparable Companies

Traded in Other Exchanges

PODD:USA GOV:Germany GOV:Germany

Address

100 Nagog Park, Acton, MA, USA, 01720

Website

https://www.insulet.com

Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetics are using it worldwide.